Driessen J J, van Egmond J, van der Pol F, Crul J F
Arch Int Pharmacodyn Ther. 1987 Mar;286(1):58-70.
The interaction of diazepam and midazolam with non-depolarizing neuromuscular blocking drugs was studied in the sciatic nerve-tibialis anterior muscle preparation of the anaesthetized cat. Both diazepam and midazolam (0.3 mg/kg i.v.) caused a significant enhancement of a constant 50% neuromuscular block, produced by infusions of vecuronium or pancuronium. Increasing the dose of midazolam from 0.3 to 1.5 mg/kg, caused no significant further potentiation of vecuronium, but decreased the onset time of potentiation. Ro 15-1788, a selective benzodiazepine antagonist, did not antagonize the vecuronium potentiation caused by midazolam 0.3 mg/kg. However, when given before midazolam (1.5 mg/kg), Ro 15-1788 delayed the onset of potentiation. Ro 15-1788 antagonized and prevented the considerable blood pressure decrease produced by midazolam 0.3 and 1.5 mg/kg. There appears to exist a ceiling to the benzodiazepine-induced blood pressure decrease and potentiation of vecuronium in the cat.
在麻醉猫的坐骨神经 - 胫前肌标本中研究了地西泮和咪达唑仑与非去极化神经肌肉阻滞药物的相互作用。地西泮和咪达唑仑(静脉注射0.3mg/kg)均显著增强了由维库溴铵或泮库溴铵输注产生的恒定50%神经肌肉阻滞。将咪达唑仑剂量从0.3mg/kg增加到1.5mg/kg,对维库溴铵没有显著的进一步增强作用,但缩短了增强作用的起效时间。选择性苯二氮䓬拮抗剂Ro 15 - 1788不能拮抗0.3mg/kg咪达唑仑引起的维库溴铵增强作用。然而,在咪达唑仑(1.5mg/kg)之前给予时,Ro 15 - 1788延迟了增强作用的起效时间。Ro 15 - 1788拮抗并预防了0.3mg/kg和1.5mg/kg咪达唑仑引起的显著血压下降。猫中苯二氮䓬诱导的血压下降和维库溴铵增强作用似乎存在一个上限。